| . | ![]() |
. |
|
by Staff Writers Washington DC (SPX) Jul 26, 2019
Most people take speech for granted, but it's actually a complex process that involves both motions of the mouth and vibrations of folded tissues, called vocal cords, within the throat. If the vocal cords sustain injuries or other lesions, a person can lose the ability to speak. Now, researchers reporting in ACS Nano have developed a wearable artificial throat that, when attached to the neck like a temporary tattoo, can transform throat movements into sounds. Scientists have developed detectors that measure movements on human skin, such as pulse or heartbeat. However, the devices typically can't convert these motions into sounds. Recently, He Tian, Yi Yang, Tian-Ling Ren and colleagues developed a prototype artificial throat with both capabilities, but because the device needed to be taped to the skin, it wasn't comfortable enough to wear for long periods of time. So the researchers wanted to develop a thinner, skin-like artificial throat that would adhere to the neck like a temporary tattoo. To make their artificial throat, the researchers laser-scribed graphene on a thin sheet of polyvinyl alcohol film. The flexible device measured 0.6 by 1.2 inches, or about double the size of a person's thumbnail. The researchers used water to attach the film to the skin over a volunteer's throat and connected it with electrodes to a small armband that contained a circuit board, microcomputer, power amplifier and decoder. When the volunteer noiselessly imitated the throat motions of speech, the instrument converted these movements into emitted sounds, such as the words "OK" and "No." The researchers say that, in the future, mute people could be trained to generate signals with their throats that the device would translate into speech.
First time human-on-a-chip predicts in vivo results based on in vitro model Washington DC (SPX) Jul 08, 2019 Hesperos Inc., pioneers of the "human-on-a-chip" in vitro system has announced the use of its innovative multi-organ model to successfully measure the concentration and metabolism of two known cardiotoxic small molecules over time, to accurately describe the drug behavior and toxic effects in vivo. The findings further support the potential of body-on-a-chip systems to transform the drug discovery process. In a study published in Nature Scientific Reports, in collaboration with AstraZeneca, Hesper ... read more
|
|||||||||||||
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2026 - SpaceDaily. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |